phenyl acetate has been researched along with Bronchopulmonary Dysplasia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Peng, W; Xu, J; Zhang, Z; Zhou, R | 1 |
| Chen, X; Pan, J; Zhang, X | 1 |
| Harms, D; Rupprecht, C; Rupprecht, T; Seybold, K; Sterlacci, W; Vieth, M | 1 |
| Balfour-Lynn, IM; Turnbull, A | 1 |
| Demir, K; Duman, N; Kargi, A; Kumral, A; Ozkan, H; Sarioglu, S; Yesilirmak, DC; Yilmaz, O | 1 |
1 review(s) available for phenyl acetate and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Recent advances in paediatric respiratory medicine.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchopulmonary Dysplasia; Ciliary Motility Disorders; Cyclopropanes; Humans; Lung Diseases, Interstitial; Medication Adherence; Pediatrics; Pulmonary Medicine; Quinolines; Saline Solution, Hypertonic; Sleep Apnea, Obstructive; Sulfides | 2016 |
1 trial(s) available for phenyl acetate and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Leukotriene receptor blockade as a life-saving treatment in severe bronchopulmonary dysplasia.
Topics: Acetates; Bronchopulmonary Dysplasia; Cyclopropanes; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Leukotriene Antagonists; Male; Prospective Studies; Quinolines; Radiography; Receptors, Leukotriene; Respiration, Artificial; Severity of Illness Index; Sulfides; Survival Rate; Treatment Outcome | 2014 |
3 other study(ies) available for phenyl acetate and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Montelukast improves bronchopulmonary dysplasia by inhibiting epithelial‑mesenchymal transition via inactivating the TGF‑β1/Smads signaling pathway.
Topics: Acetates; Alveolar Epithelial Cells; Animals; Bronchopulmonary Dysplasia; Cell Hypoxia; Cyclopropanes; Disease Models, Animal; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Quinolines; Rats; Signal Transduction; Smad Proteins; Sulfides; Transforming Growth Factor beta1 | 2020 |
Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms.
Topics: Acetates; Animals; Animals, Newborn; Apoptosis; Bronchopulmonary Dysplasia; Cyclopropanes; Disease Models, Animal; Hyperoxia; Interleukin-1beta; Interleukin-6; Lung; Lung Injury; Mice; Mice, Inbred C57BL; Oxidative Stress; Quinolines; Receptors, Leukotriene; Sulfides; Tumor Necrosis Factor-alpha | 2019 |
Clarithromycin, montelukast, and pentoxifylline combination treatment ameliorates experimental neonatal hyperoxic lung injury.
Topics: Acetates; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Bronchopulmonary Dysplasia; Clarithromycin; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Humans; Infant, Newborn; Leukotriene Antagonists; Oxygen Inhalation Therapy; Pentoxifylline; Quinolines; Rats; Sulfides | 2008 |